Iq Eq Fund Management (Ireland) LTD Crispr Therapeutics Ag Transaction History
Iq Eq Fund Management (Ireland) LTD
- $833 Million
- Q1 2025
A detailed history of Iq Eq Fund Management (Ireland) LTD transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Iq Eq Fund Management (Ireland) LTD holds 65,195 shares of CRSP stock, worth $3.76 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
65,195
Previous 36,264
79.78%
Holding current value
$3.76 Million
Previous $1.43 Million
55.43%
% of portfolio
0.27%
Previous 0.17%
Shares
4 transactions
Others Institutions Holding CRSP
# of Institutions
481Shares Held
63.9MCall Options Held
2.16MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$587 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$350 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$219 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$160 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.54MShares$147 Million0.06% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.5B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....